Physical and functional bivalency observed among TCR/CD3 complexes isolated from primary T cells

Adam G. Schrum, Diana Gil, Laurence A. Turka, Ed Palmer

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Unlike BCR and secreted Ig, TCR expression is not thought to occur in a bivalent form. The conventional monovalent model of TCR/ CD3 is supported by published studies of complexes solubilized in the detergent digitonin, in which bivalency was not observed. We revisited the issue of TCR valency by examining complexes isolated from primary αβ T cells after solubilization in digitonin. Using immunoprecipitation followed by flow cytometry, we unexpectedly observed TCR/CD3 complexes that contained two TCRs per complex. Standard anti-TCR Abs, being bivalent themselves, tended to bind with double occupancy to bivalent TCRs; this property masked the presence of the second TCR per complex in certain Ab binding assays, which may partially explain why previous data did not reveal these bivalent complexes. We also found that the prevalence of bivalency among fully assembled, mature TCR/CD3 complexes was sufficient to impact the functional performance of immunoprecipitated TCRs in binding antigenic peptide/MHC-Ig fusion proteins. Both TCR positions per bivalent complex required an Ag-specific TCR to effect optimal binding to these soluble ligands. Therefore, we conclude that in primary T cells, TCR/CD3 complexes can be found that are physically and functionally bivalent. The expression of bivalent TCR/CD3 complexes has implications regarding potential mechanisms by which Ag may trigger signaling. It also suggests the possibility that the potential for bivalent expression could represent a general feature of Ag receptors.

Original languageEnglish (US)
Pages (from-to)870-878
Number of pages9
JournalJournal of Immunology
Volume187
Issue number2
DOIs
StatePublished - Jul 15 2011

Fingerprint

T-Cell Antigen Receptor-CD3 Complex
T-Lymphocytes
Digitonin
Immunoprecipitation
Detergents
Flow Cytometry
Ligands
Proteins

ASJC Scopus subject areas

  • Immunology

Cite this

Physical and functional bivalency observed among TCR/CD3 complexes isolated from primary T cells. / Schrum, Adam G.; Gil, Diana; Turka, Laurence A.; Palmer, Ed.

In: Journal of Immunology, Vol. 187, No. 2, 15.07.2011, p. 870-878.

Research output: Contribution to journalArticle

Schrum, Adam G. ; Gil, Diana ; Turka, Laurence A. ; Palmer, Ed. / Physical and functional bivalency observed among TCR/CD3 complexes isolated from primary T cells. In: Journal of Immunology. 2011 ; Vol. 187, No. 2. pp. 870-878.
@article{db25f2166972487f9016ff43badf34d3,
title = "Physical and functional bivalency observed among TCR/CD3 complexes isolated from primary T cells",
abstract = "Unlike BCR and secreted Ig, TCR expression is not thought to occur in a bivalent form. The conventional monovalent model of TCR/ CD3 is supported by published studies of complexes solubilized in the detergent digitonin, in which bivalency was not observed. We revisited the issue of TCR valency by examining complexes isolated from primary αβ T cells after solubilization in digitonin. Using immunoprecipitation followed by flow cytometry, we unexpectedly observed TCR/CD3 complexes that contained two TCRs per complex. Standard anti-TCR Abs, being bivalent themselves, tended to bind with double occupancy to bivalent TCRs; this property masked the presence of the second TCR per complex in certain Ab binding assays, which may partially explain why previous data did not reveal these bivalent complexes. We also found that the prevalence of bivalency among fully assembled, mature TCR/CD3 complexes was sufficient to impact the functional performance of immunoprecipitated TCRs in binding antigenic peptide/MHC-Ig fusion proteins. Both TCR positions per bivalent complex required an Ag-specific TCR to effect optimal binding to these soluble ligands. Therefore, we conclude that in primary T cells, TCR/CD3 complexes can be found that are physically and functionally bivalent. The expression of bivalent TCR/CD3 complexes has implications regarding potential mechanisms by which Ag may trigger signaling. It also suggests the possibility that the potential for bivalent expression could represent a general feature of Ag receptors.",
author = "Schrum, {Adam G.} and Diana Gil and Turka, {Laurence A.} and Ed Palmer",
year = "2011",
month = "7",
day = "15",
doi = "10.4049/jimmunol.1100538",
language = "English (US)",
volume = "187",
pages = "870--878",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "2",

}

TY - JOUR

T1 - Physical and functional bivalency observed among TCR/CD3 complexes isolated from primary T cells

AU - Schrum, Adam G.

AU - Gil, Diana

AU - Turka, Laurence A.

AU - Palmer, Ed

PY - 2011/7/15

Y1 - 2011/7/15

N2 - Unlike BCR and secreted Ig, TCR expression is not thought to occur in a bivalent form. The conventional monovalent model of TCR/ CD3 is supported by published studies of complexes solubilized in the detergent digitonin, in which bivalency was not observed. We revisited the issue of TCR valency by examining complexes isolated from primary αβ T cells after solubilization in digitonin. Using immunoprecipitation followed by flow cytometry, we unexpectedly observed TCR/CD3 complexes that contained two TCRs per complex. Standard anti-TCR Abs, being bivalent themselves, tended to bind with double occupancy to bivalent TCRs; this property masked the presence of the second TCR per complex in certain Ab binding assays, which may partially explain why previous data did not reveal these bivalent complexes. We also found that the prevalence of bivalency among fully assembled, mature TCR/CD3 complexes was sufficient to impact the functional performance of immunoprecipitated TCRs in binding antigenic peptide/MHC-Ig fusion proteins. Both TCR positions per bivalent complex required an Ag-specific TCR to effect optimal binding to these soluble ligands. Therefore, we conclude that in primary T cells, TCR/CD3 complexes can be found that are physically and functionally bivalent. The expression of bivalent TCR/CD3 complexes has implications regarding potential mechanisms by which Ag may trigger signaling. It also suggests the possibility that the potential for bivalent expression could represent a general feature of Ag receptors.

AB - Unlike BCR and secreted Ig, TCR expression is not thought to occur in a bivalent form. The conventional monovalent model of TCR/ CD3 is supported by published studies of complexes solubilized in the detergent digitonin, in which bivalency was not observed. We revisited the issue of TCR valency by examining complexes isolated from primary αβ T cells after solubilization in digitonin. Using immunoprecipitation followed by flow cytometry, we unexpectedly observed TCR/CD3 complexes that contained two TCRs per complex. Standard anti-TCR Abs, being bivalent themselves, tended to bind with double occupancy to bivalent TCRs; this property masked the presence of the second TCR per complex in certain Ab binding assays, which may partially explain why previous data did not reveal these bivalent complexes. We also found that the prevalence of bivalency among fully assembled, mature TCR/CD3 complexes was sufficient to impact the functional performance of immunoprecipitated TCRs in binding antigenic peptide/MHC-Ig fusion proteins. Both TCR positions per bivalent complex required an Ag-specific TCR to effect optimal binding to these soluble ligands. Therefore, we conclude that in primary T cells, TCR/CD3 complexes can be found that are physically and functionally bivalent. The expression of bivalent TCR/CD3 complexes has implications regarding potential mechanisms by which Ag may trigger signaling. It also suggests the possibility that the potential for bivalent expression could represent a general feature of Ag receptors.

UR - http://www.scopus.com/inward/record.url?scp=79960484634&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960484634&partnerID=8YFLogxK

U2 - 10.4049/jimmunol.1100538

DO - 10.4049/jimmunol.1100538

M3 - Article

C2 - 21666056

AN - SCOPUS:79960484634

VL - 187

SP - 870

EP - 878

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 2

ER -